Skip to main content
SpringerLink
Log in

Endogenous Regulation of Sodium Pump Activity

  • Chapter
Ion Channels and Ion Pumps

Part of the book series: Endocrinology and Metabolism ((EAM,volume 6))

  • 115 Accesses

Abstract

Following volume expansion, the plasma acquires the capacity to cause natriuresis, inhibit membrane sodium transport, and increase vascular reactivity. The discovery of the atrial natriuretic factor (ANF) in 1981 provided a partial explanation for the first of these phenomena, but it was rapidly recognized that ANF was not an inhibitor of sodium transport,1 nor was it able to increase vascular reactivity.2 Thus it became apparent that a 20-year effort to identify a plasma-borne substance that was natriuretic by virtue of its ability to inhibit cellular sodium transport and which might increase vascular reactivity as a result of a similar action on vascular smooth muscle had not yet succeeded. Ten years later, in 1991, this effort appeared to have achieved its first major breakthrough.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thibault G, Garcia R, Cantin M, Genest J. Atrial natriuretic factor, characterization and partial purification. Hypertension 1983; 5:1–75–1–80.

    Google Scholar 

  2. Pamnani MB, Clough DL, Chen JS, Link WT, Haddy FJ. Effects of atrial extract on sodium transport and blood pressure in the rat. Proc Soc Exptl Biol Med 1984; 176:123–131.

    CAS  Google Scholar 

  3. August JT, Nelson DH, Thorn GW. Response of normal subjects to large amounts of aldosterone. J Clin Invest 1958; 37:1549–1555.

    Article  PubMed  CAS  Google Scholar 

  4. Relman AS, Schwartz WB. The effect of DOC A on electrolyte balance in normal man and its relation to sodium chloride intake. Yale J Biol Med 1952; 24:540–558.

    PubMed  CAS  Google Scholar 

  5. De Wardener HE, Mills IH, Clapham WF, Hayter CJ. Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sei 1961; 21:249–258.

    Google Scholar 

  6. Buckalew VA, Nelson DB. Natriuretic and sodium transport inhibiting activity in plasma of volume expanded dogs. Kid Inter 1974; 5:12–22.

    Article  CAS  Google Scholar 

  7. Clarkson EM, Talner LB, De Wardener HE. The effect of plasma from blood volume expanded dogs on sodium, potassium and PAH transport of renal tubule fragments. Clin Sei 1970; 38:617–627.

    CAS  Google Scholar 

  8. De Bold AJ. Atrial natriuretic factor of the rat heart. Studies on isolation and properties. Proc Soc Exptl Biol Med 1982; 170:133–138.

    Google Scholar 

  9. Overbeck HW, Pamnani MB, Akera T, Brody TM, Haddy FJ. Depressed function of a ouabain sensitive sodium-potassium pump in blood vessels from renal hypertensive dogs. Circ Res 1976; 38:11–48–11–52.

    Google Scholar 

  10. Clough DL, Huot SJ, Pamnani MB, Haddy FJ. Decreased myocardial Na, K-ATPase activity in rats with reduced renal mass-saline hypertension. J Hypertension 1985; 3:583–589.

    Article  CAS  Google Scholar 

  11. Solandt DY, Nassim R, Cowan CR. Hypertensive effect of blood from hypertensive dogs. Lancet 1940; 1:873–874.

    Article  Google Scholar 

  12. Gordon DB, Drury DR, Schapiro S. The salt-fed animal as a test object for pressor substances in the blood of hypertensive animals. Am J Physiol 1953; 175:123–128.

    PubMed  CAS  Google Scholar 

  13. Dahl LK, Knudsen KD, Iwai J. Humoral transmission of hypertension: Evidence from parabiosis. Circ Res 1969; 24/25:1–21–1–33.

    Google Scholar 

  14. Haddy FJ, Overbeck HW. The sodium, potassium pump in volume expanded hypertension. Life Sei 1976; 19:935–948.

    Article  CAS  Google Scholar 

  15. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol 1977; 232:C167–C173.

    Google Scholar 

  16. Blaustein MP, Ashida T, Hamlyn JM. Sodium metabolism and hypertension: How are they linked? Klin Wochenschr 1987; 65:21–32.

    PubMed  Google Scholar 

  17. Rasgado-Flores H, Blaustein MP. Calcium influx and sodium efflux mediated by the Na/Ca exchanger in giant barnacle muscle cells are promoted by intracellular Ca. Biophysic J 1986; 49:546a.

    Google Scholar 

  18. Losse H, Wehmeyer H, Wessels F. The water and electrolyte content of erythrocytes in arterial hypertension. Klin Wochenschr 1960; 38:393–395.

    Article  PubMed  CAS  Google Scholar 

  19. MacGregor G, De Wardener H. Is a circulating sodium transport inhibitor involved in the pathogenesis of essential hypertension? In: Fregly M, Kare M, eds. The role of salt in cardiovascular hypertension. New York: Academic Press; 1982:331–343.

    Google Scholar 

  20. Poston L. Endogenous sodium pump inhibitors: A role in essential hypertension? Clin Sei 1987; 72:647–655.

    CAS  Google Scholar 

  21. Poston L, Sewell RB, Wilkinson SP, Richardson PJ, Williams R, Clarkson EM, MacGregor GA, De Wardener HE. Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J 1981; 282:847–849.

    Article  CAS  Google Scholar 

  22. Edmondson RPS, MacGregor GA. Leucocyte cation transport in essential hypertension: its relation to the renin-angiotensin system. Br Med J 1981; 282:1267–1269.

    Article  CAS  Google Scholar 

  23. Gruber K, Rudel LL, Bullock BC. Increased circulating levels of an endogenous digoxin-like factor in hypertensive monkeys. Hypertension 1982; 4:348–354.

    PubMed  CAS  Google Scholar 

  24. Gruber KA, Whitaker JM, Buckalew VM. Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature 1980; 287:743–745.

    Article  PubMed  CAS  Google Scholar 

  25. Hamlyn JM, Ringel R, Schaeffer J, Levinson PD, Hamilton BP, Kowarski AA, Blaustein M. A criculating inhibitor of (Na, K)-ATPase associated with essential hypertension. Nature 1982; 300:650–652.

    Article  PubMed  CAS  Google Scholar 

  26. Huot S, Pamnani MB, Clough DL, Haddy FJ. The role of sodium intake, the Na-K-pump and a ouabain-like humoral agent in the genesis of reduced renal mass hypertension. Am J Nephrol 1983; 3:92–99.

    Article  PubMed  CAS  Google Scholar 

  27. Huot SJ, Pamnani MB, Clough DL, Buggy J, Bryant HJ, Harder DR, Haddy FJ. Sodium-potassium pump activity in reduced renal mass hypertension. Hypertension 1983; 5:1–94–1–100.

    Google Scholar 

  28. Pamnani MB, Whitehorn WV, Clough DL, Haddy FJ. Effects of canrenone on blood pressure in rats with reduced renal mass. Am J Hypertens 1990; 3:188–195.

    PubMed  CAS  Google Scholar 

  29. Brody MJ, Johnson AK. Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation, and hypertension. In: Martini L, Ganong WF, eds. Frontiers in Neuroendocrinology. New York: Raven Press; 1980:249–292.

    Google Scholar 

  30. Millett JA, Holland SA, Alaghband-Zadeh J, De Wardener HE. Na, K-ATPase-inhibiting and glucose-6-phosphate dehydrogenase-stimulating activity of plasma and hypothalamus of the Okamoto spontaneously hypertensive rat. J Endocrinol 1986; 108:69–73.

    Article  PubMed  CAS  Google Scholar 

  31. Holland S, Millett J, Alaghband-Zadeh J, De Wardener H, Pamnani M, Haddy F. Cytochemically detectable glucose-6-phosphate dehydrogenase-stimulating/Na-K-ATPase-inhibiting activity of plasma and hypothalamus in reduced renal mass hypertension. Am J Hypertens 1991; 4:315–320.

    PubMed  CAS  Google Scholar 

  32. Wauquier I, Pernollet M-G, Grichois M-L, Lacour B, Meyer P, Devynck M-A. Endogenous digitalislike circulating substances in spontaneously hypertensive rats. Hypertension 1988; 12:108–116.

    PubMed  CAS  Google Scholar 

  33. Hamlyn JM. Increased levels of a humoral digitalis-like factor in deoxycorticosterone acetate-induced hypertension in the pig. J Endocrinol 1989; 122:409–420.

    Article  PubMed  CAS  Google Scholar 

  34. Josephson L, Cantley LC. Isolation of a potent (Na, K)-ATPase inhibitor from striated muscle. Biochemistry 1977; 16:4572–4578.

    Article  PubMed  CAS  Google Scholar 

  35. Cantley LC, Josephson L, Warner R, Yanagisawa M, Lechene C, Guidotti G. Vanadate is potent (Na, K)-ATPase inhibitor found in ATP derived from muscle. J Biol Chem 1977; 252:7421–7423.

    PubMed  CAS  Google Scholar 

  36. Haupert GT, Sancho JM. Sodium transport inhibitor from bovine hypothalamus. Proc Natl Acad Sei USA 1979; 76:4658–4660.

    Article  CAS  Google Scholar 

  37. Fishman MC. Endogenous digitalis-like activity in mammalian brain. Proc Natl Acad Sei USA 1979; 76:4661–4663.

    Article  CAS  Google Scholar 

  38. Godfraind T, Castenada-Hernandez G. Properties of a digitalis-like factor extracted from guinea pig brain. Arch Int Pharmacodyn 1981; 250:316–317.

    PubMed  CAS  Google Scholar 

  39. Hallaq HA, Haupert GT. Positive inotropic effects of the endogenous Na/K-transporting ATPase inhibitor from the hypothalamus. Proc Natl Acad Sei USA 1989; 86:10080–10084.

    Article  CAS  Google Scholar 

  40. Haber E, Haupert GT. The search for a hypothalamic Na, K-ATPase inhibitor. Hypertension 1987; 9:315.

    CAS  Google Scholar 

  41. Carilli CT, Berne M, Cantley LC, Haupert GT. Hypothalamic factor inhibits the (Na, K)-ATPase from the extracellular surface. J Biol Chem 1985; 260:1027–1031.

    PubMed  CAS  Google Scholar 

  42. Shimoni Y, Gotsman M, Deutsch J, Kachalsky S, Lichtstein D. Endogenous ouabain-like compound increases heart muscle contractility. Nature 1984; 307:369–371.

    Article  PubMed  CAS  Google Scholar 

  43. Lichtstein D, Samuelov S. Endogenous “ouabain like” activity in rat brain. Biochem Biophys Res Commun 1980; 96:1518–1523.

    Article  PubMed  CAS  Google Scholar 

  44. Morgan K, Lewis MD, Spurlock G, Collins PA, Foord SM, Southgate K, Scanion MF, Mir MA. Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells. J Biol Chem 1985; 260:13595–13600.

    PubMed  CAS  Google Scholar 

  45. Mir MA, Chappell SP, Morgan K, Lewis MD, Scanion MF, Lewis MJ. Hypothalamic sodium transport inhibitor and vascular reactivity. J Hypertension 1986; 4:S233–S235.

    Article  CAS  Google Scholar 

  46. Halperin J. Schaff er R, Galvez L, Malare S. Ouabain-like activity in human cerebrospinal fluid. Proc Natl Acad Sei USA 1983; 80:6101–6104.

    CAS  Google Scholar 

  47. Lichtstein D, Mine D, Bourrit A, Deutsch J, Karlish SJD, Belmaker H, Rimon R, Palo J. Evidence for the presence of a ouabain-like compound in human cerebrospinal fluid. Brain Res 1985; 325:13–19.

    Article  PubMed  CAS  Google Scholar 

  48. Takahashi H, Matsusawa M, Suga K, Ikegaki I, Nishimura M, Yoshimura M, Ihara N, Yamada H, Sano Y. Hypothalamic digitalis-like substance is released with sodium loading in rats. Am J Hypertens 1988; 1:147–151.

    Google Scholar 

  49. Schreiber V, Stepan J, Gregorova I, Krejcikova J. Crossed digoxin immunoreactivity in chromatography fractions of rat adrenal extract. Biochem Pharmacol 1981; 30:805.

    Article  PubMed  CAS  Google Scholar 

  50. Castenada-Hernandez G, Godfraind T. Effect of high sodium intake on tissue distribution of endogenous digitalis-like material in the rat. Clin Sei USA 1984; 66:225.

    Google Scholar 

  51. Ng Y-C, Akera T, Han C-S, Braselton WE, Kennedy RH, Temma K, Brody T, Sato P. Ascorbic acid: An endogenous inhibitor of isolated Na, K-ATPase. Biochem Pharmacol 1985; 34:2525–2530.

    Article  PubMed  CAS  Google Scholar 

  52. Doris PA. Immunological evidence that the adrenal gland is the source of an endogenous digitalis-like factor in the rat. Endocrinology 1988; 123:2440–2444.

    Article  PubMed  CAS  Google Scholar 

  53. Doris PA, Kilgore MW, Durham D, Alberts D, Stocco DM. An endogenous digitalis-like factor derived from the adrenal gland: Studies of adrenocortical tumor cells. Endocrinology 1989; 125:2580–2586.

    Article  PubMed  CAS  Google Scholar 

  54. Gault MH, Vasdev S, Longerich L, Johnson E, Farid N, Legal Y, Prabhakaran V, Fine A. Evidence for an adrenal contribution to plasma digitalis-like factors. Clin Physiol Biochem 1988; 6:253–261.

    PubMed  CAS  Google Scholar 

  55. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sei USA 1991; 88:6259–6263.

    Article  CAS  Google Scholar 

  56. Pernollet MG, Ali RM, Meyer P, Devynck MA. Are the circulating digitalislike compounds of adrenal origin? J Hypertension 1986; 4(suppl 6):382–384.

    Google Scholar 

  57. Shaikh IM, Lau BWC, Siegfried BA, Valdes R. Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. J Biol Chem 1991; 266:13672–13678.

    PubMed  CAS  Google Scholar 

  58. Tamura M, Lam T-T, Inagami T. Isolation and characterization of a specific endogenous Na, K-ATPase inhibitor from bovine adrenal. Biochemistry 1988; 27:4244–4253.

    Article  PubMed  CAS  Google Scholar 

  59. Tamura M, Lam T-T, Inagami T. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal. Biochem Biophys Res Commun 1987; 149:468.

    Article  PubMed  CAS  Google Scholar 

  60. Doris PA. Digoxin-like immunoreactivity in rat plasma: Effect of sodium and calcium intake. Life Sei 1988; 42:783–790.

    Article  CAS  Google Scholar 

  61. Doris PA, Stocco DM. An endogenous digitalis-like factor derived from the adrenal gland: Studies of adrenal tissue from various sources. Endocrinology 1989; 125:2573–2579.

    Article  PubMed  CAS  Google Scholar 

  62. Goto A, Yamada K, Ishii M, Yoshioka M, Ishiguro T, Eguchi C, Sagimoto T. Purification and characterization of human urine-derived digitalis-like factor. Biochem Biophys Res Commun 1988; 154:847–853.

    Article  PubMed  CAS  Google Scholar 

  63. Goto A, Yamada K, Ishii M, Yoshioka MIT, Sugimoto T. The effects of urinary digitalis-like factor on cultured vascular smooth muscle cells. Hypertension 1988; 11:645–650.

    PubMed  CAS  Google Scholar 

  64. Goto A, Yamada K, Ishii M, Yoshioka M, Ishiguro T, Eguchi C, Sugimoto T. Urinary sodium pump inhibitor raises cytosolic free calcium concentration in rat aorta. Hypertension 1989; 13:916–921.

    PubMed  CAS  Google Scholar 

  65. Goto A, Ishiguro T, Yamada K, Ishii M, Yoshioka M, Eguchi C, Shimora M, Sugimoto T. Isolation of a urinary digitalis-like factor indistinguishable from digoxin. 1990; 173:1093–1101.

    CAS  Google Scholar 

  66. Goto A, Tamada K, Ishii M, Sugimoto T. Does digoxin-like immunoreactivity really represent natriuretic hormone? Nephron 1990; 54:99–100.

    Article  PubMed  CAS  Google Scholar 

  67. Mathews WR, DuCharme DW, Hamlyn JM, Harris DW, Mandel F, Clark MA, Ludens JH. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension 1991; 17:930–935.

    PubMed  CAS  Google Scholar 

  68. Ludens JH, Clark MA, DuCharme DW, Lutzke BS, Mandel F, Mathews WR, Sutter DM, Hamlyn JM. Purification of an endogenous digitalislike factor from human plasma for structural analysis. Hypertension 1991; 17:923–929.

    PubMed  CAS  Google Scholar 

  69. Harris DW, Clark MA, Fisher JF, Hamlyn JM, Kolbasa KP, Ludens JH, DuCharme DW. Development of an immunoassay for endogenous digitalislike factor. Hypertension 1991; 17:936–943.

    PubMed  CAS  Google Scholar 

  70. Bova S, Blaustein MP, Ludens JH, Harris DW, DuCharme DW, Hamlyn J. Effects of an endogenous ouabainlike compound on heart and aorta. Hypertension 1991; 17:944–950.

    PubMed  CAS  Google Scholar 

  71. Deray G, Rieu M, Devynck MA, Perilollet M-G, Chanson P, Luton JP, Meyer P. Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly. N Engl J Med 1987; 316:575–580.

    Article  PubMed  CAS  Google Scholar 

  72. Ng LL, Evans DJ. Leucocyte sodium transport in acromegaly. Clin Endocrinol 1987; 26:471–480.

    Article  CAS  Google Scholar 

  73. Ng LL, Hockaday TDR. Endogenous digitalis-like factors in acromegaly. N Engl J Med 1987; 317:572–573.

    PubMed  CAS  Google Scholar 

  74. Soszynski P, Slowinska-Szrednicka J, Kasperlik-Zaluska A, Zgliczynski S. Endogenous natriueretic factors: Atrial natriuretic hormone and digitalis-like substance in Cushing’s syndrome. J Endocrinol 1990; 129:453–458.

    Article  Google Scholar 

  75. Soszynski P, Slowinska-Srzednicka J, Zgliczynski S. Increased activity of digoxin-like substance in low-renin hypertension on acromegaly. Clin Exp Hypertens 1990; A12:533–549.

    Article  Google Scholar 

  76. Graves SW, Adler G, Stuenkel C, Sharma K, Brena A, Majoub J. Increases in plasma digitalis-like factor activity during insulin-induced hypoglycemia. Neuroendocrinology 1989; 49:586–591.

    Article  PubMed  CAS  Google Scholar 

  77. Giampetro O, Cleirco A, Gregori G, Bertoli S, Del Chicca MG, Miccoli R, Luchetti A, Cruschelli L, Navalesi R. Increased urinary excretion of digoxin-like immunoreactive substance by insulin-dependent diabetic patients: A linkage with hypertension? Clin Chem 1988; 34:2418–2422.

    Google Scholar 

  78. Shilo L, Adawi A, Soloman G, Shenkman L. Endogenous digoxin-like immunoreactivity in congestive heart failure. Br Med J 1987; 295:415–416.

    Article  CAS  Google Scholar 

  79. Bagrov AY, Fedorova OV, Maslova MN, Roukoyatkina NI, Ukhanova MV, Zhabko EP. Endogenous plasma Na, K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction. Cardiovasc Res 1991; 25:371–377.

    Article  PubMed  Google Scholar 

  80. Kerkez S, Poston L, Wolfe CD, Quartero HW, Carabelli P, Petruckevitch A, Hiltom PJ. A longitudinal study of maternal digoxin-like immunoreactive substances in normotensive pregnancy and pregnancy-induced hypertension. Am J Obstet Gynecol 1990; 162:783–787.

    PubMed  CAS  Google Scholar 

  81. Morris JF, McEachern MD, Poston L, Smith SE, Mulvany MJ, Hilton PJ. Evidence for an inhibitor of leucocyte sodium transport in the serum of neonates. Clin Sei 1987; 73:291–297.

    CAS  Google Scholar 

  82. Ebarra H, Suzuki S, Nagashima K, Shimano S, Kuruome T. Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: Relationship to renal excretion of sodium. J Pediatrics 1986; 108:760–762.

    Article  Google Scholar 

  83. Seccombe DW, Pudek MR, Whitfield MF, Jacobson BE, Wittmann BK, King JF. Perinatal changes in a digoxin-like immunoreactive substance. Pediatric Research 1984; 18:1097–1099.

    Article  PubMed  CAS  Google Scholar 

  84. Valdes R, Graves SW, Brown BA, Landt M. Endogenous substance in newborn infants causing false positive digoxin measurements. J Pediatrics 1983; 102:947–950.

    Article  CAS  Google Scholar 

  85. Delva P, Capra C, Degan M, Minuz P, Covi G, Milan L, Steele A, Lechi A. High plasma levels of a ouabain-like factor in normal pregnancy and in pre-eclampsia. Eur J Clin Invest 1989; 19:95–100.

    PubMed  CAS  Google Scholar 

  86. Fievet P, Gregoire I, Fourmier A, Roth D, Siegenthaler G, El Esper N, Favre H, De Bold A. Ouabain-like natriuretic factor and atrial natriuretic factor in pregnancy. Kid Inter 1988; 34:S89–S92.

    Google Scholar 

  87. Ringel R, Pinkas G, Hamlyn J, Mullins L, Hamilton B. Endogenous inhibition of red blood cell Na, K-ATPase in essential and pregnancy-induced hypertension. Clin Exp Hypertens 1989; A11:587–601.

    Article  Google Scholar 

  88. Goodlin R, Makowski EL. Fetal endotoxins and complications of pregnancy. Western J Med 1988; 148:590–592.

    CAS  Google Scholar 

  89. Witherspoon L, Shuler S, Alyea K, Fegueroa J, Neely H. Digoxin-like substance in term pregnancy, newborns, and renal failure. J Nucl Med 1986; 27:1418–1422.

    PubMed  CAS  Google Scholar 

  90. Kovacs L, Lichardus B, Bircak J, Ponecova M, Masurova A, Stefanilova J, Bruchac D, Sulyok E. Endogenous digoxin-like immunoreactivity in urine of preterm infants with late hyponatremia. Contrib Nephrol 1988; 67:145–148.

    PubMed  CAS  Google Scholar 

  91. Morris JF, Poston L, Wolfe CD, Hilton PJ. A comparison of endogenous digoxin-like immunoreactivity and sodium transport inhibitory activity in umbilical arterial and venous serum. Clin Sei 1988; 75:577–579.

    CAS  Google Scholar 

Download references

Authors
  1. Peter A. Doris
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. 48323, 2104 Rhine Road, West Bloomfield, MI, USA

    Piero P. Foà M.D., Sc.D. (Professor Emeritus) (Professor Emeritus)

  2. Department of Physiology, Wayne State University, 48202, Detroit, MI, USA

    Piero P. Foà M.D., Sc.D. (Professor Emeritus) (Professor Emeritus)

  3. Section of Endocrinology,Department of Internal Medicine,School of Medicine, Wayne State University, 48202, Detroit, MI, USA

    Mary F. Walsh Ph.D. (Assistant Professor) (Assistant Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Doris, P.A. (1994). Endogenous Regulation of Sodium Pump Activity. In: Foà, P.P., Walsh, M.F. (eds) Ion Channels and Ion Pumps. Endocrinology and Metabolism, vol 6. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2596-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2596-6_12

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7599-2

  • Online ISBN: 978-1-4612-2596-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation